Yuka Yamamoto (Y Yamamoto)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Ankylosing Spondylitis

Tyrosine Kinase

Positron Emission Tomography

Top Venues

Journal of neuro-oncology

EJNMMI research

European journal of hybrid imaging

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Takashi Norikane, Mariko Ishimura, Katsuya Mitamura, Yuka Yamamoto, Hanae Arai-Okuda, Yuri Manabe, Mitsumasa Murao, Riku Morita, Takafumi Obata, Kenichi Tanaka, Makiko Murota, Nobuhiro Kanaji, Yoshihiro Nishiyama
Texture Features of 18 F-Fluorodeoxyglucose Positron Emission Tomography for Predicting Programmed Death-Ligand-1 Levels in Non-Small Cell Lung Cancer. Journal of clinical medicine 13 (6) (2024)
Takashi Norikane, Mariko Ishimura, Katsuya Mitamura, Yuka Yamamoto, Hanae Arai-Okuda, Yuri Manabe, Mitsumasa Murao, Riku Morita, Takafumi Obata, Kenichi Tanaka, Makiko Murota, Nobuhiro Kanaji, Yoshihiro Nishiyama
Texture Features of 18 F-Fluorodeoxyglucose Positron Emission Tomography for Predicting Programmed Death-Ligand-1 Levels in Non-Small Cell Lung Cancer. Journal of clinical medicine 13 (6) (2024)
Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yuri Manabe, Mitsumasa Murao, Hanae Arai-Okuda, Tetsuhiro Hatakeyama, Keisuke Miyake, Yoshihiro Nishiyama
Comparative evaluation of 11 C-methionine and 18 F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of neuro-oncology (2023)
Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yuri Manabe, Mitsumasa Murao, Hanae Arai-Okuda, Tetsuhiro Hatakeyama, Keisuke Miyake, Yoshihiro Nishiyama
Comparative evaluation of 11 C-methionine and 18 F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of neuro-oncology 166 (1) (2023)
Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yuri Manabe, Mitsumasa Murao, Hanae Arai-Okuda, Tetsuhiro Hatakeyama, Keisuke Miyake, Yoshihiro Nishiyama
Comparative evaluation of 11 C-methionine and 18 F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of neuro-oncology 166 (1) (2023)
Yusuke Ushio, Risa Wakiya, T Kameda, Shusaku Nakashima, Hiromi Shimada, T Miyagi, Koichi Sugihara, Rina Mino, M Mizusaki, K Chujo, R Kagawa, H Yamaguchi, Yuka Yamamoto, Takashi Norikane, Y Nishiyama, Norimitsu Kadowaki, Hiroaki Dobashi
Effects of anti-interleukin-17 treatment on osteoblastic activity as assessed by 18 F-sodium fluoride positron emission tomography/computed tomography in ankylosing spondylitis: a case report. Scandinavian journal of rheumatology (2023)
Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yuri Manabe, Mitsumasa Murao, Hanae Arai-Okuda, Tetsuhiro Hatakeyama, Keisuke Miyake, Yoshihiro Nishiyama
Comparative evaluation of 11 C-methionine and 18 F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma. Journal of neuro-oncology 166 (1) (2023)
Kenichi Tanaka, Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yukito Maeda, Kengo Fujimoto, Yasukage Takami, Mariko Ishimura, Hanae Arai-Okuda, Yoichiro Tohi, Nobuyuki Kudomi, Mikio Sugimoto, Yoshihiro Nishiyama
Quantitative [ 99m Tc]Tc-MDP SPECT/CT correlated with [ 18 F]NaF PET/CT for bone metastases in patients with prostate cancer. EJNMMI physics 9 (1) (2022)
Kengo Fujimoto, Takashi Norikane, Yuka Yamamoto, Yasukage Takami, Makiko Murota, Hiromi Shimada, Hiroaki Dobashi, Yoshihiro Nishiyama
Cardiac Sarcoidosis Mimicking Lymphoma in a Patient With Sjogren's Syndrome. Korean circulation journal 52 (9) (2022)
Katsuya Mitamura, Takashi Norikane, Yuka Yamamoto, Kengo Fujimoto, Yasukage Takami, Hiroshi Hoshikawa, Jun Toyohara, Yoshihiro Nishiyama
Interim 4'-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PET. EJNMMI research 11 (1) (2021)
Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Yukito Maeda, Kenichi Tanaka, Tetsuhiro Hatakeyama, Keisuke Miyake, Jun Toyohara, Yoshihiro Nishiyama
Correlation of 4'-[methyl-11C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma. EJNMMI research 11 (1) (2021)
Katsuya Mitamura, Hanae Arai-Okuda, Yuka Yamamoto, Takashi Norikane, Yasukage Takami, Kengo Fujimoto, Risa Wakiya, Hiroki Ozaki, Hiroaki Dobashi, Yoshihiro Nishiyama
Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease. EJNMMI research 10 (1) (2020)
Hanae Arai-Okuda, Takashi Norikane, Yuka Yamamoto, Katsuya Mitamura, Kengo Fujimoto, Yasukage Takami, Risa Wakiya, Shusaku Nakashima, Hiroaki Dobashi, Yoshihiro Nishiyama
18F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes. European journal of hybrid imaging 4 (1) (2020)
Ayumi Ihara-Nishishita, Takashi Norikane, Katsuya Mitamura, Yuka Yamamoto, Kengo Fujimoto, Yasukage Takami, Emi Ibuki, Nobuyuki Kudomi, Hiroshi Hoshikawa, Jun Toyohara, Yoshihiro Nishiyama
Texture indices of 4'-[methyl-11C]-thiothymidine uptake predict p16 status in patients with newly diagnosed oropharyngeal squamous cell carcinoma: comparison with 18F-FDG uptake. European journal of hybrid imaging 4 (1) (2020)